Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC23937402;7403;7404 chr2:178773991;178773990;178773989chr2:179638718;179638717;179638716
N2AB23937402;7403;7404 chr2:178773991;178773990;178773989chr2:179638718;179638717;179638716
N2A23937402;7403;7404 chr2:178773991;178773990;178773989chr2:179638718;179638717;179638716
N2B23477264;7265;7266 chr2:178773991;178773990;178773989chr2:179638718;179638717;179638716
Novex-123477264;7265;7266 chr2:178773991;178773990;178773989chr2:179638718;179638717;179638716
Novex-223477264;7265;7266 chr2:178773991;178773990;178773989chr2:179638718;179638717;179638716
Novex-323937402;7403;7404 chr2:178773991;178773990;178773989chr2:179638718;179638717;179638716

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAA
  • RefSeq wild type template codon: GTT
  • Domain: Ig-13
  • Domain position: 38
  • Structural Position: 55
  • Q(SASA): 0.5932
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/R rs754687695 0.514 0.029 N 0.284 0.163 0.238705975628 gnomAD-2.1.1 1.2E-05 None None None None N None 0 0 None 0 0 None 0 None 4.62E-05 1.76E-05 0
Q/R rs754687695 0.514 0.029 N 0.284 0.163 0.238705975628 gnomAD-4.0.0 1.16293E-05 None None None None N None 0 0 None 0 0 None 3.74392E-05 0 8.99306E-06 0 8.27924E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.1564 likely_benign 0.1512 benign -0.145 Destabilizing 0.016 N 0.341 neutral None None None None N
Q/C 0.2971 likely_benign 0.29 benign 0.208 Stabilizing 0.864 D 0.313 neutral None None None None N
Q/D 0.2233 likely_benign 0.2226 benign -0.026 Destabilizing 0.016 N 0.269 neutral None None None None N
Q/E 0.0735 likely_benign 0.0737 benign -0.062 Destabilizing None N 0.143 neutral N 0.503463507 None None N
Q/F 0.363 ambiguous 0.358 ambiguous -0.383 Destabilizing 0.214 N 0.382 neutral None None None None N
Q/G 0.2305 likely_benign 0.223 benign -0.317 Destabilizing 0.072 N 0.409 neutral None None None None N
Q/H 0.1117 likely_benign 0.1095 benign -0.18 Destabilizing None N 0.193 neutral N 0.5050425 None None N
Q/I 0.1503 likely_benign 0.1501 benign 0.221 Stabilizing 0.038 N 0.42 neutral None None None None N
Q/K 0.0664 likely_benign 0.0669 benign 0.022 Stabilizing 0.012 N 0.349 neutral N 0.460183465 None None N
Q/L 0.0913 likely_benign 0.0891 benign 0.221 Stabilizing None N 0.202 neutral N 0.49384687 None None N
Q/M 0.1883 likely_benign 0.1877 benign 0.361 Stabilizing 0.214 N 0.266 neutral None None None None N
Q/N 0.1599 likely_benign 0.1585 benign -0.161 Destabilizing 0.072 N 0.249 neutral None None None None N
Q/P 0.5187 ambiguous 0.5289 ambiguous 0.126 Stabilizing 0.106 N 0.402 neutral D 0.592472329 None None N
Q/R 0.0824 likely_benign 0.0813 benign 0.204 Stabilizing 0.029 N 0.284 neutral N 0.499604191 None None N
Q/S 0.1755 likely_benign 0.1725 benign -0.167 Destabilizing 0.016 N 0.271 neutral None None None None N
Q/T 0.1318 likely_benign 0.1316 benign -0.063 Destabilizing 0.072 N 0.379 neutral None None None None N
Q/V 0.1152 likely_benign 0.115 benign 0.126 Stabilizing None N 0.225 neutral None None None None N
Q/W 0.3243 likely_benign 0.3214 benign -0.41 Destabilizing 0.864 D 0.316 neutral None None None None N
Q/Y 0.2465 likely_benign 0.2426 benign -0.148 Destabilizing 0.072 N 0.415 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.